米氮平：用于治疗接受姑息治疗的转移性肉瘤患者的慢性难治性恶心和呕吐的一种抗抑郁药：病例报告
Mirtazapine: An Antidepressant for Treating Chronic, Refractory Nausea and Vomiting in a Patient With Metastatic Sarcoma Receiving Palliative Care: A Case Report.
作者信息
Ziaei Seyedeh Golnaz, Tahmasebi Mamak
机构信息
Division of Palliative Medicine, Radio Oncology Department Tehran University of Medical Sciences Tehran Iran.
Cancer Research Center Cancer Institute, Imam Khomeini Hospital, Tehran University of Medical Sciences Tehran Iran.
出版信息
Clin Case Rep. 2024 Nov 14;12(11):e9570. doi: 10.1002/ccr3.9570. eCollection 2024 Nov.
Managing chronic, refractory nausea and vomiting in advanced cancer patients is challenging, especially when unrelated to cancer treatment. Mirtazapine, a tetracyclic antidepressant, effectively alleviates these symptoms, improving quality of life. It offers a promising palliative care alternative, addressing multiple symptoms and reducing polypharmacy, thereby enhancing patient satisfaction.
管理晚期癌症患者的慢性难治性恶心和呕吐具有挑战性，尤其是当这些症状与癌症治疗无关时。米氮平，一种四环类抗抑郁药，能有效缓解这些症状，提高生活质量。它提供了一种有前景的姑息治疗选择，可解决多种症状并减少联合用药，从而提高患者满意度。
Zotero 插件